NASDAQ:AMDA

Amedica Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

$1.58

0.00 (0.00 %)

(As of 06/21/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.52

▼

$1.58

50-Day Range

$0.09

▼

$2.19

52-Week Range

$0.18

▼

$6.40

Volume406,286 shs

Average Volume1.07 million shs

Market Capitalization$18.75 million

P/E RatioN/A

Dividend YieldN/A

Beta-1.24

Receive AMDA News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedica and its competitors with MarketBeat's FREE daily newsletter.

About Amedica

SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.

Form 10-Q Sintx Technologies, Inc. For: Mar 31 - StreetInsider.com
May 14, 2021 | streetinsider.com

SINTX Technologies Shares Q3 Business Update and Identifies Growth Opportunities for 2021 - GlobeNewswire
November 16, 2020 | globenewswire.com

CTL Amedica increases global reach with license from Taiwan - Dallas Business Journal
September 28, 2020 | bizjournals.com

Global Spine Surgery Products Market 2020 Industry Statistics on Key Trends, Growth and Opportunities to 2025 - StreetInsider.com
September 4, 2020 | streetinsider.com

The global spinal implants and devices market was valued at $11,356.59 million in 2019 and is projected to reach $15,054.07 million by 2027 at a CAGR of 5.7% from 2020 to 2027 - Yahoo Finance UK
September 2, 2020 | uk.finance.yahoo.com

Assure Holdings Appoints Gary Bennett as Vice President of Revenue - StreetInsider.com
August 14, 2020 | streetinsider.com

Global Drug Delivery Partnering Deals Report 2014-2020: Access to 1,000+ Deal Records Sorted by Company A-Z, Stage of Development, Deal Type, Therapy Focus, and Technology Type - Yahoo Finance
May 18, 2020 | finance.yahoo.com

Global Musculoskeletal Partnering (2014 to 2020) - Deal Trends, Players and Financials - ResearchAndMarkets.com - Yahoo Finance
May 11, 2020 | finance.yahoo.com

2020 Insights on the Worldwide Pharma, Biotech and Diagnostics Manufacturing and Supply Partnering Terms and Agreements - Yahoo Finance UK
April 14, 2020 | uk.finance.yahoo.com

Global Dental Partnering Deal Trends, Players & Financials 2010-2020 - ResearchAndMarkets.com - Yahoo Finance
April 9, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AMDA
Previous Symbol
CUSIPN/A
CIK1269026
Webwww.amedica.com
Phone(855) 839-3500
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$11.23 million
Price / Sales1.67
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.80 per share
Price / Book0.88

Profitability

EPS (Most Recent Fiscal Year)($3.13)
Net Income$-9,320,000.00
Net Margins-139.62%
Return on Equity-148.60%
Return on Assets-67.83%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares11,870,000
Market Cap$18.75 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.73 out of 5 stars

Medical Sector

1295th out of 2,105 stocks

Surgical & Medical Instruments Industry

118th out of 174 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Amedica.

2.4 Community Rank

Outperform Votes
Amedica has received 307 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Amedica has received 333 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Amedica has received 52.03% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote “Outperform” if you believe AMDA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Amedica does not currently pay a dividend.
Dividend Growth
Amedica does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Amedica insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.90% of the stock of Amedica is held by insiders.
Percentage Held by Institutions
Only 3.72% of the stock of Amedica is held by institutions.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Amedica are expected to grow in the coming year, from ($2.93) to ($2.85) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Amedica is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Amedica is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Amedica has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Amedica (NASDAQ:AMDA) Frequently Asked Questions

What stocks does MarketBeat like better than Amedica?

Wall Street analysts have given Amedica a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Amedica wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Amedica's earnings last quarter?

Amedica Co. (NASDAQ:AMDA) issued its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative trailing twelve-month return on equity of 148.60% and a negative net margin of 139.62%.
View Amedica's earnings history.

When did Amedica's stock split? How did Amedica's stock split work?

Amedica shares reverse split on the morning of Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split.

Who are Amedica's key executives?

Amedica's management team includes the following people:

B. Sonny Bal, Chairman, President, Chief Executive Officer & CFO
David O’Brien, Chief Operating Officer
Bryan J. McEntire, Chief Scientific Officer
Donald J. Bray, Vice President-Business Development
Michael Marcroft, Vice President-Business Development

Who are some of Amedica's key competitors?

Some companies that are related to Amedica include Nephros (NEPHD), Sensus Healthcare (SRTS), Delcath Systems (DCTH), Obalon Therapeutics (OBLN), Aethlon Medical (AEMD), Neovasc (NVCN), Plus Therapeutics (PSTV), AIT Therapeutics (AITB), Hancock Jaffe Laboratories (HJLI), STRATA Skin Sciences (SSKN), Motus GI (MOTS), INVO Bioscience (INVO), Daxor (DXR), Sintx Technologies (SINT) and InspireMD (NSPR).
View all of AMDA's competitors.

What other stocks do shareholders of Amedica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), General Electric (GE), Net Element (NETE), Pernix Therapeutics (PTX), Synergy Pharmaceuticals (SGYP), Anavex Life Sciences (AVXL), (GBSN) (GBSN), (SLS) and (SPHS).

What is Amedica's stock symbol?

Amedica trades on the NASDAQ under the ticker symbol "AMDA."

What is Amedica's stock price today?

One share of AMDA stock can currently be purchased for approximately $1.58.

How much money does Amedica make?

Amedica has a market capitalization of $18.75 million and generates $11.23 million in revenue each year. The medical equipment provider earns $-9,320,000.00 in net income (profit) each year or ($3.13) on an earnings per share basis.

What is Amedica's official website?

The official website for Amedica is www.amedica.com.

Where are Amedica's headquarters?

Amedica is headquartered at 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119.

How can I contact Amedica?

Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at (855) 839-3500 or via email at [email protected]

This page was last updated on 6/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Amedica Stock Forecast, Price & News

About Amedica

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

2.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

0.0 Company Ownership

1.3 Earnings and Valuation

Amedica (NASDAQ:AMDA) Frequently Asked Questions

What stocks does MarketBeat like better than Amedica?

How were Amedica's earnings last quarter?

When did Amedica's stock split? How did Amedica's stock split work?

Who are Amedica's key executives?

Who are some of Amedica's key competitors?

What other stocks do shareholders of Amedica own?

What is Amedica's stock symbol?

What is Amedica's stock price today?

How much money does Amedica make?

What is Amedica's official website?

Where are Amedica's headquarters?

How can I contact Amedica?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™